To mark Fragile X awareness day today and the 35th anniversary of the Fragile X Society, Queen’s University and the Fragile X ...
While Harmony management has not disclosed future plans for ZYN002, Jefferies analysts expect the asset to be shelved.
Servier has signed a definitive agreement with Kaerus Bioscience to acquire a potential Fragile X syndrome (FXS) treatment, KER-0193.
Fragile X syndrome, the most common form of inherited intellectual disability, may be unfolding in brain cells even before birth, despite typically going undiagnosed until age 3 or later. A new study ...
Shares of Harmony Biosciences Holdings, Inc. HRMY lost 16.56% on Sept. 24 after the company announced the failure of the late-stage registrational RECONNECT study on pipeline candidate ZYN002 in ...
Fragile X syndrome (FXS) and autism spectrum disorder (ASD) sometimes occur together. While FXS is a known genetic cause of ASD, not everyone who receives an FXS diagnosis is autistic, and not all ...
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it has expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ...
The most common first diagnosis of Alport syndrome in Japan is during the universal age-3 urine screening. In 60% of these ...